Gluformin G 1 New Tablet PR is a combination oral antidiabetic medication containing Glimepiride 1 mg and Metformin 500 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, leading to reduced blood glucose levels. The combination of these two agents provides complementary mechanisms of action, offering effective glycemic regulation in patients inadequately controlled by diet and exercise alone or monotherapy. Gluformin G 1 New Tablet PR is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and physical activity. It is important to monitor blood glucose levels regularly and assess renal function prior to and during treatment due to the risk of lactic acidosis associated with metformin. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypoglycemia primarily attributable to glimepiride. This medication should be used under medical supervision, with dose adjustments tailored to individual patient response and tolerability.

Dosage & How to Use